These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30358439)

  • 1. HDAC8 inhibition ameliorates pulmonary fibrosis.
    Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β
    Guo W; Saito S; Sanchez CG; Zhuang Y; Gongora Rosero RE; Shan B; Luo F; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L936-L944. PubMed ID: 28336812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.
    Guo W; Shan B; Klingsberg RC; Qin X; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2009 Nov; 297(5):L864-70. PubMed ID: 19700647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
    Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
    Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation.
    Glenisson W; Castronovo V; Waltregny D
    Biochim Biophys Acta; 2007 Oct; 1773(10):1572-82. PubMed ID: 17610967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
    Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
    Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
    Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
    Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures.
    Cho JS; Moon YM; Park IH; Um JY; Kang JH; Kim TH; Lee SH; Kang HJ; Lee HM
    Am J Rhinol Allergy; 2013 Jan; 27(1):18-23. PubMed ID: 23406592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
    Zhang J; Wang H; Chen H; Li H; Xu P; Liu B; Zhang Q; Lv C; Song X
    Autophagy; 2022 Nov; 18(11):2636-2655. PubMed ID: 35427207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
    Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
    Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anoctamin-1 is induced by TGF-β and contributes to lung myofibroblast differentiation.
    Reed EB; Orbeta S; Miao BA; Sitikov A; Chen B; Levitan I; Solway J; Mutlu GM; Fang Y; Mongin AA; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L111-L123. PubMed ID: 38084409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
    Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
    Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
    Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
    Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.